Skip to main content
Top
Published in: BMC Palliative Care 1/2021

Open Access 01-12-2021 | Care | Research article

Assessing the quality of deliberative stakeholder consultations involving allied health professionals in pediatric palliative care and hematology/oncology in Canada

Authors: Vasiliki Rahimzadeh, Cristina Longo, Justin Gagnon, Conrad Fernandez, Gillian Bartlett

Published in: BMC Palliative Care | Issue 1/2021

Login to get access

Abstract

Background

In this paper we assess the quality of six deliberative stakeholder consultations regarding the implementation of a precision diagnostic for life-threatening pediatric brain tumors. Decision makers who base policy recommendations on the outputs of consultative exercises can presuppose that all deliberants are well informed of the policy issue, that participation in the deliberative process was fair, and that overcoming implementation barriers will necessarily result in practice change. Additional evidence is therefore needed to substantiate the informational quality of the deliberation, measure the equality of participation and study the effects on stakeholder reasoning to appropriately guide uptake of proposed recommendation(s).

Methods

Using the DeVries framework for assessing the deliberative quality, we analyzed data from 44 post-consultation evaluation surveys completed by pediatric oncology and palliative care teams at two tertiary pediatric healthcare centers in Canada. We also conducted turn-taking and word-contribution analyses from the text transcriptions of each deliberation to assess equality of participation using descriptive statistics.

Results

Deliberants agreed the quality of the deliberative process was fair (median ratings ranging from 9–10 out of 10) and the opportunities to receive expert information and discuss with others about the implementation of a new LDT were helpful (9.5 out of 10). While the session improved understanding of the implementation barriers and opportunities, it had marginal effects on deliberants’ reasoning about whether LDTs would change their own clinical practice (3–10 out of 10). Participation was proportionate in at least four of the six deliberations, where no deliberant took more than 20% of total turns and contributed equal to, or less than 20% of total words.

Conclusion

The quality assessment we performed demonstrates high informational value and perceived fairness of two deliberative stakeholder consultations involving pediatric palliative care and oncology teams in Canada. Quality assessments can reveal how the process of deliberation unfolds, whether deliberative outputs are the result of equitable participation among deliberants and what, if any, stakeholder voices may be missing. Such assessments should be routinely reported as a condition of methodological rigor and trustworthiness of deliberative stakeholder engagement research.
Appendix
Available only for authorised users
Footnotes
1
Deliberative outputs are syntheses of collective decisions, opinions and statements from deliberants on the policy issue at hand, with limited attention to the discursive elements underpinning them.
 
2
Analytical outputs, in contrast, are those which “treats participants’ statements as socio-cultural products, contingent on the discursive context within which they are produced” [14].
 
Literature
1.
go back to reference Jones DTW, Bandopadhayay P, Jabado N. The Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas. Annu Rev Genet. 2019;53:483–503.CrossRef Jones DTW, Bandopadhayay P, Jabado N. The Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas. Annu Rev Genet. 2019;53:483–503.CrossRef
2.
go back to reference Adel Fahmideh M, Lavebratt C, Tettamanti G, Schüz J, Röösli M, Kjaerheim K, et al. A Weighted Genetic Risk Score of Adult Glioma Susceptibility Loci Associated with Pediatric Brain Tumor Risk. Sci Rep. 2019;9:8–11.CrossRef Adel Fahmideh M, Lavebratt C, Tettamanti G, Schüz J, Röösli M, Kjaerheim K, et al. A Weighted Genetic Risk Score of Adult Glioma Susceptibility Loci Associated with Pediatric Brain Tumor Risk. Sci Rep. 2019;9:8–11.CrossRef
3.
go back to reference Crimi L. Master’s Thesis. Barriers to Personalized Medicine in Pediatrics: The Implementation of A Novel Pharmacogenomic Test for Pediatric Neuroblastoma: McGill University; 2015. Crimi L. Master’s Thesis. Barriers to Personalized Medicine in Pediatrics: The Implementation of A Novel Pharmacogenomic Test for Pediatric Neuroblastoma: McGill University; 2015.
4.
go back to reference Weaver SM, Heinze KE, Kelly KP, Wiener L, Casey RL, et al. Palliative Care as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer. 2015;62(Suppl 5):S829–33.CrossRef Weaver SM, Heinze KE, Kelly KP, Wiener L, Casey RL, et al. Palliative Care as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer. 2015;62(Suppl 5):S829–33.CrossRef
5.
go back to reference Cooley C, Adeodu S, Aldred H, Beesley S, Leung A, Thacker L. Paediatric palliative care: a lack of research-based evidence. Int J Palliat Care Nurs. 2013;6(7):346–51.CrossRef Cooley C, Adeodu S, Aldred H, Beesley S, Leung A, Thacker L. Paediatric palliative care: a lack of research-based evidence. Int J Palliat Care Nurs. 2013;6(7):346–51.CrossRef
6.
go back to reference Feudtner C. Collaborative communication in pediatric palliative care: a foundation for problem-solving and decision-making. Pediatr Clin N Am. 2007;54:583–607.CrossRef Feudtner C. Collaborative communication in pediatric palliative care: a foundation for problem-solving and decision-making. Pediatr Clin N Am. 2007;54:583–607.CrossRef
7.
go back to reference Fraser LK, Bluebond-Langner M, Ling J. Advances and challenges in European paediatric palliative care. Med Sci. 2020;8:20. Fraser LK, Bluebond-Langner M, Ling J. Advances and challenges in European paediatric palliative care. Med Sci. 2020;8:20.
8.
go back to reference Gagnon J, Rahimzadeh V, Longo C, Nugus P, Bartlett G. Understanding how professionals cultures impact implementation of a pediatric oncology genomic test: using ethnographic participant observation in deliberative stakeholder consultations. J Health Organ Manag. 2019;33:919–28.CrossRef Gagnon J, Rahimzadeh V, Longo C, Nugus P, Bartlett G. Understanding how professionals cultures impact implementation of a pediatric oncology genomic test: using ethnographic participant observation in deliberative stakeholder consultations. J Health Organ Manag. 2019;33:919–28.CrossRef
9.
go back to reference Fishkin J. When the people speak: deliberative democracy and public consultation: Oxford University Press; 2009. Fishkin J. When the people speak: deliberative democracy and public consultation: Oxford University Press; 2009.
10.
go back to reference Dryzek J. Deliberative democracy and beyond: liberals, critics, contestations; 2000. Dryzek J. Deliberative democracy and beyond: liberals, critics, contestations; 2000.
11.
go back to reference Rychetnik L. Which public and why deliberate ? - a scoping review of public deliberation in public health and health policy. Soc Sci Med. 2015;131:114–21.CrossRef Rychetnik L. Which public and why deliberate ? - a scoping review of public deliberation in public health and health policy. Soc Sci Med. 2015;131:114–21.CrossRef
12.
go back to reference Abelson J, Forest P-G, Eyles J, Smith P, Martin E, Gauvin F-P. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003;57:239–51.CrossRef Abelson J, Forest P-G, Eyles J, Smith P, Martin E, Gauvin F-P. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003;57:239–51.CrossRef
13.
go back to reference Abelson J, Blacksher EA, Li KK, Boesveld SE, Goold SD. Public Deliberation in Health Policy and Bioethics: Mapping an emerging, interdisciplinary field. J Deliberative Democr. 2013;9:5. Abelson J, Blacksher EA, Li KK, Boesveld SE, Goold SD. Public Deliberation in Health Policy and Bioethics: Mapping an emerging, interdisciplinary field. J Deliberative Democr. 2013;9:5.
14.
go back to reference Doherty KO, Burgess MM. Defining Deliberative Outputs in a Public Engagement about Biobanks. Health Law Rev. 2008;16:4–6. Doherty KO, Burgess MM. Defining Deliberative Outputs in a Public Engagement about Biobanks. Health Law Rev. 2008;16:4–6.
15.
go back to reference Kim SYH, Wall IF, Stanczyk A, De Vries R. Assessing the public’s views in research ethics controversies: deliberative democracy and bioethics as natural allies. J Empir Res Hum Res Ethics JERHRE. 2009;4:3–16.CrossRef Kim SYH, Wall IF, Stanczyk A, De Vries R. Assessing the public’s views in research ethics controversies: deliberative democracy and bioethics as natural allies. J Empir Res Hum Res Ethics JERHRE. 2009;4:3–16.CrossRef
16.
go back to reference De Vries R, Stanczyk A, Wall IF, Uhlmann R, Damschroder LJ, Kim SY. Assessing the quality of democratic deliberation: A case study of public deliberation on the ethics of surrogate consent for research. Soc Sci Med. 2010;70:1896–903.CrossRef De Vries R, Stanczyk A, Wall IF, Uhlmann R, Damschroder LJ, Kim SY. Assessing the quality of democratic deliberation: A case study of public deliberation on the ethics of surrogate consent for research. Soc Sci Med. 2010;70:1896–903.CrossRef
17.
go back to reference De Vries R, Stanczyk AE, Ryan K, a., Kim SYH. A framework for assessing the quality of democratic deliberation: enhancing deliberation as a tool for bioethics. J Empir Res Hum Res Ethics Int J. 2011;6:3–17.CrossRef De Vries R, Stanczyk AE, Ryan K, a., Kim SYH. A framework for assessing the quality of democratic deliberation: enhancing deliberation as a tool for bioethics. J Empir Res Hum Res Ethics Int J. 2011;6:3–17.CrossRef
18.
go back to reference Longo C, Rahimzadeh V, O’doherty K, Bartlett G. Addressing ethical challenges at the intersection of pharmacogenomics and primary care using deliberative consultations. Pharmacogenomics. 2016;17(16):1795-805. Longo C, Rahimzadeh V, O’doherty K, Bartlett G. Addressing ethical challenges at the intersection of pharmacogenomics and primary care using deliberative consultations. Pharmacogenomics. 2016;17(16):1795-805.
19.
go back to reference Degeling C, Carter SM, Rychetnik L. Which public and why deliberate? - A scoping review of public deliberation in public health and health policy research. Soc Sci Med. 2015;131:114–21.CrossRef Degeling C, Carter SM, Rychetnik L. Which public and why deliberate? - A scoping review of public deliberation in public health and health policy research. Soc Sci Med. 2015;131:114–21.CrossRef
20.
go back to reference O’Doherty KC. Synthesising the outputs of deliberation: Extracting meaningful results from a public forum. J Public Deliberation. 2013;9(1). O’Doherty KC. Synthesising the outputs of deliberation: Extracting meaningful results from a public forum. J Public Deliberation. 2013;9(1).
21.
go back to reference Carman KL, Mallery C, Maurer M, Wang G, Garfinkel S, Yang M, et al. Effectiveness of public deliberation methods for gathering input on issues in healthcare: Results from a randomized trial. Soc Sci Med. 2015;133:11–20.CrossRef Carman KL, Mallery C, Maurer M, Wang G, Garfinkel S, Yang M, et al. Effectiveness of public deliberation methods for gathering input on issues in healthcare: Results from a randomized trial. Soc Sci Med. 2015;133:11–20.CrossRef
22.
go back to reference Levine DR, Mandrell BN, Sykes A, Pritchard M, Gibson D, Symons HJ, et al. Patients’ and parents’ needs, attitudes, and perceptions about early palliative care integration in pediatric oncology. JAMA Oncol. 2017;3:1214–20.CrossRef Levine DR, Mandrell BN, Sykes A, Pritchard M, Gibson D, Symons HJ, et al. Patients’ and parents’ needs, attitudes, and perceptions about early palliative care integration in pediatric oncology. JAMA Oncol. 2017;3:1214–20.CrossRef
23.
go back to reference Ranallo L. Improving the quality of end-of-life care in pediatric oncology patients through the early implementation of palliative care. J Pediatr Oncol Nurs. 2017;34:374–80.CrossRef Ranallo L. Improving the quality of end-of-life care in pediatric oncology patients through the early implementation of palliative care. J Pediatr Oncol Nurs. 2017;34:374–80.CrossRef
24.
go back to reference Szymczak JE, Schall T, Hill DL, Walter JK, Parikh S, DiDomenico C, et al. Pediatric oncology providers’ perceptions of a palliative care service: the influence of emotional esteem and emotional labor. J Pain Symptom Manag. 2018;55:1260–8.CrossRef Szymczak JE, Schall T, Hill DL, Walter JK, Parikh S, DiDomenico C, et al. Pediatric oncology providers’ perceptions of a palliative care service: the influence of emotional esteem and emotional labor. J Pain Symptom Manag. 2018;55:1260–8.CrossRef
25.
go back to reference Marcus KL, Santos G, Ciapponi A, Comandé D, Bilodeau M, Wolfe J, et al. Impact of Specialized Pediatric Palliative Care: A Systematic Review. J Pain Symptom Manag. 2020;59:339–364.e10.CrossRef Marcus KL, Santos G, Ciapponi A, Comandé D, Bilodeau M, Wolfe J, et al. Impact of Specialized Pediatric Palliative Care: A Systematic Review. J Pain Symptom Manag. 2020;59:339–364.e10.CrossRef
26.
go back to reference Odeniyi F, Nathanson PG, Schall TE, Walter JK. Communication challenges of oncologists and intensivists caring for pediatric oncology patients: a qualitative study. J Pain Symptom Manag. 2017;54:909–15.CrossRef Odeniyi F, Nathanson PG, Schall TE, Walter JK. Communication challenges of oncologists and intensivists caring for pediatric oncology patients: a qualitative study. J Pain Symptom Manag. 2017;54:909–15.CrossRef
27.
go back to reference Lafont C. Deliberation, participation, and democratic legitimacy: Should deliberative mini-publics shape public policy? J Polit Philos. 2015;23:40–63.CrossRef Lafont C. Deliberation, participation, and democratic legitimacy: Should deliberative mini-publics shape public policy? J Polit Philos. 2015;23:40–63.CrossRef
Metadata
Title
Assessing the quality of deliberative stakeholder consultations involving allied health professionals in pediatric palliative care and hematology/oncology in Canada
Authors
Vasiliki Rahimzadeh
Cristina Longo
Justin Gagnon
Conrad Fernandez
Gillian Bartlett
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Care
Published in
BMC Palliative Care / Issue 1/2021
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-021-00884-2

Other articles of this Issue 1/2021

BMC Palliative Care 1/2021 Go to the issue